Kimio Mizuno

Title: Kimio Mizuno: Innovator in Physiologically Active Peptide Composition

Introduction

Kimio Mizuno is a notable inventor based in Shizuoka, Japan. He has made significant contributions to the field of pharmaceutical compositions, particularly in the area of nasal administration. His innovative work has led to the development of a unique peptide composition that enhances drug absorption through the nasal mucosa.

Latest Patents

Mizuno holds a patent for a "Physiologically active peptide composition for nasal administration." This patent describes a nasal administration powder composition that contains a physiologically active peptide as an active ingredient. The composition is designed to be efficiently absorbed through the nasal mucosa by incorporating a water-soluble organic acid as an absorption promoter. The patent also outlines that the composition may include a diluent, and lists various organic acids that can be used, such as succinic acid, citric acid, and L-glutamic acid.

Career Highlights

Kimio Mizuno is associated with Toyo Jozo Company, Ltd., where he has been able to apply his expertise in peptide compositions. His work has not only advanced the field of nasal drug delivery but has also contributed to the overall understanding of peptide absorption mechanisms.

Collaborations

Mizuno has collaborated with notable colleagues, including Nakayuki Yamamoto and Hideo Sakakibara. These collaborations have likely enriched his research and development efforts, leading to innovative solutions in the pharmaceutical industry.

Conclusion

Kimio Mizuno's contributions to the field of physiologically active peptide compositions highlight his role as an important inventor in the pharmaceutical sector. His innovative approaches to drug delivery continue to pave the way for advancements in medical treatments.